Close

William Blair Starts PhaseBio Pharmaceuticals Inc. (PHAS) at Outperform

September 11, 2019 6:40 AM EDT
Get Alerts PHAS Hot Sheet
Price: $0.07 --0%

Rating Summary:
    2 Buy, 4 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE

William Blair analyst Matt Phipps initiates coverage on PhaseBio Pharmaceuticals Inc. (NASDAQ: PHAS) with a Outperform rating.

For an analyst ratings summary and ratings history on PhaseBio Pharmaceuticals Inc. click here. For more ratings news on PhaseBio Pharmaceuticals Inc. click here.

Shares of PhaseBio Pharmaceuticals Inc. closed at $5.20 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

William Blair